Table 4.
All | Aged 19–29 years | Aged 30–39 years | Aged 40–49 years | Aged > 50 years | |
---|---|---|---|---|---|
RSbasal (%) | − 7.9 ± 5.8 | − 7.4 ± 5.6 | − 7.4 ± 5.5 | − 6.9 ± 5.0 | − 9.7 ± 6.6 |
RSmidatrial (%) | − 7.9 ± 5.4 | − 7.5 ± 5.1 | − 7.5 ± 5.0 | − 8.5 ± 6.9 | − 8.8 ± 5.4 |
RSsuperior (%) | − 9.1 ± 8.4 | − 8.4 ± 8.6 | − 8.9 ± 8.4 | − 10.8 ± 9.2 | − 9.6 ± 7.6 |
CSbasal (%) | 16.5 ± 9.0†† | 15.1 ± 7.9††† | 18.7 ± 9.9†/†††† | 17.0 ± 11.0 | 16.7 ± 8.8 |
CSmidatrial (%) | 13.0 ± 8.4 | 11.9 ± 7.5 | 12.8 ± 7.5 | 13.2 ± 10.3 | 14.8 ± 9.5 |
CSsuperior (%) | 15.9 ± 14.6†† | 15.7 ± 13.1††† | 15.5 ± 15.3 | 14.8 ± 20.3 | 16.9 ± 13.6 |
LSbasal (%) | 7.5 ± 5.2 | 6.8 ± 5.1 | 7.9 ± 5.6 | 7.9 ± 4.6 | 8.5 ± 5.0‡ |
LSmidatrial (%) | 11.4 ± 7.5‡‡ | 10.2 ± 7.1‡ | 11.9 ± 7.9‡‡‡ | 12.6 ± 6.8‡‡‡‡ | 12.6 ± 8.0‡‡‡‡‡ |
LSsuperior (%) | 11.0 ± 8.7‡‡ | 10.7 ± 8.4‡ | 10.0 ± 9.0 | 11.5 ± 9.5 | 12.1 ± 8.5‡‡‡‡‡ |
3DSbasal (%) | − 5.4 ± 5.4 | − 5.0 ± 5.2 | − 4.8 ± 5.1 | − 4.5 ± 4.6§ | − 6.8 ± 6.4 |
3DSmidatrial (%) | − 5.0 ± 4.7 | − 4.7 ± 4.8 | − 4.8 ± 4.4 | − 4.9 ± 5.5§ | − 5.6 ± 4.3 |
3DSsuperior (%) | − 6.0 ± 7.3 | − 5.4 ± 6.8 | − 5.9 ± 8.0 | − 8.5 ± 7.5 | − 6.2 ± 7.4 |
ASbasal (%) | 22.7 ± 13.0 | 20.3 ± 10.9$$$$$ | 24.6 ± 14.5 | 27.1 ± 14.1$ | 23.9 ± 14.1 |
ASmidatrial (%) | 25.8 ± 15.3$$$ | 23.3 ± 15.3$$$$$ | 26.5 ± 13.3 | 27.0 ± 14.0 | 29.2 ± 16.9$$ |
ASsuperior (%) | 30.6 ± 29.1$$$/$$$$ | 30.4 ± 26.8 | 29.6 ± 31.6 | 27.8 ± 35.8 | 32.5 ± 27.8 |
†p < 0.05 vs. CS basal Aged 19–29 years; ††p < 0.05 vs. CS midatrial All; †††p < 0.05 vs. CS midatrial Aged 19–29; ††††p < 0.05 vs. CS midatrial Aged 30–39
‡p < 0.05 vs. LSbasal Aged 19–29 years; ‡‡p < 0.05 vs. LSbasal All; ‡‡‡p < 0.05 vs. LSbasal Aged 30–39 years; ‡‡‡‡p < 0.05 vs. LSbasal Aged 40–49 years; ‡‡‡‡‡p < 0.05 vs. LSbasal Aged 50 < years
§p < 0.05 vs. 3DSsuperior Aged 40–49 years
$p < 0.05 vs. ASbasal Aged 20–29; $$p < 0.05 vs. ASmidatrial Aged 20–29; $$$p < 0.05 vs. ASbasal All; $$$$p < 0.05 vs. ASmidatrial All; $$$$$p < 0.05 vs. ASsuperior Aged 19–29